Edison Liu
From Wikipedia, the free encyclopedia
Edison Tak-Bun Liu is an American chemist and former president and CEO of The Jackson Laboratory and director of its NCI-designated Cancer Center (2012–2021). He previously served as founding executive director of the Genome Institute of Singapore (GIS), chairman of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007–2013).[1][2]
From 1997 to 2001, he was scientific director of the National Cancer Institute's Division of Clinical Sciences. At the University of North Carolina at Chapel Hill (1987–1996), he held leadership roles at the Lineberger Comprehensive Cancer Center, UNC School of Public Health, and CALGB.[3][4]
Edison T. Liu earned his B.S. in Chemistry and Psychology from Stanford University in 1973, followed by an M.D. from the Stanford University School of Medicine in 1978. He completed his internship (1978–1979) and residency (1979–1980) at Barnes Hospital, affiliated with Washington University in St. Louis. Liu then pursued an oncology fellowship at Stanford University (1980–1982) and a hematology fellowship at University of California San Francisco, Moffitt Hospital (1982–1985).[5] From 1983 to 1987, he was a postdoctoral fellow in the Department of Microbiology at the University of California at San Francisco, working in the laboratory of Dr. J. Michael Bishop.[6]
